Target Organs and Levels of Evidence for TR-395
Toxicology and Carcinogenesis Studies of Probenecid (CASRN 57-66-9) in F344/N Rats and B6C3F1 Mice (Gavage Studies)
| Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
|---|---|---|---|
| Probenecid 57-66-9 |
11/20/1990 | Gavage R&M:0,100,400 MG/KG/50 PER GROUP |
T.S.I. Mason Laboratories, Inc. |
Levels of Evidence
Male Rats: No Evidence
Female Rats: No Evidence
| Type | Organ/Tissue (Lesion) |
|---|---|
| Other Considerations |
|
Male Mice: No Evidence
Female Mice: Some Evidence
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|